Celanese (NYSE:CE) Upgraded to Hold at ValuEngine
Several other research analysts have also commented on CE. Zacks Investment Research upgraded shares of Celanese from a sell rating to a hold rating in a research note on Tuesday, April 2nd. Barclays reduced their price objective on shares of Celanese from $125.00 to $120.00 and set an overweight rating for the company in a research note on Tuesday, April 9th. Deutsche Bank lowered shares of Celanese from a buy rating to a hold rating and set a $110.00 price objective for the company. in a research note on Sunday, April 14th. Alembic Global Advisors set a $95.00 price objective on shares of Celanese and gave the stock a sell rating in a research note on Monday, April 22nd. Finally, Nomura boosted their price objective on shares of Celanese from $109.00 to $114.00 and gave the stock a neutral rating in a research note on Wednesday, April 24th. Nine equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company’s stock. The stock presently has an average rating of Hold and an average price target of $119.53.
NYSE:CE opened at $104.19 on Wednesday. Celanese has a one year low of $82.91 and a one year high of $119.29. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.58 and a quick ratio of 1.03. The stock has a market capitalization of $13.33 billion, a PE ratio of 9.69, a price-to-earnings-growth ratio of 1.00 and a beta of 1.38.
In other Celanese news, Director John K. Wulff sold 9,175 shares of the business’s stock in a transaction that occurred on Thursday, April 25th. The shares were sold at an average price of $108.32, for a total transaction of $993,836.00. Following the sale, the director now owns 19,872 shares of the company’s stock, valued at approximately $2,152,535.04. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.57% of the stock is currently owned by insiders.
A number of large investors have recently added to or reduced their stakes in CE. Advisory Alpha LLC purchased a new stake in shares of Celanese in the 1st quarter valued at $27,000. Acima Private Wealth LLC purchased a new stake in shares of Celanese in the 4th quarter valued at $31,000. Pearl River Capital LLC purchased a new stake in shares of Celanese in the 4th quarter valued at $36,000. Prime Capital Investment Advisors LLC purchased a new stake in shares of Celanese in the 4th quarter valued at $37,000. Finally, Investors Research Corp purchased a new stake in shares of Celanese in the 1st quarter valued at $41,000. 97.25% of the stock is currently owned by institutional investors.
Celanese Corporation, a technology and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. The company operates through Engineered Materials, Acetate Tow, and Acetyl Chain segments. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.
Featured Article: Using other technical indicators with support levels
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Celanese Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celanese and related companies with MarketBeat.com's FREE daily email newsletter.